Avalo Therapeutics, Inc. (AVTX): Shareholders' Equity
$83.05M
As of 2025-12-31
$448.66M
As of 2026-06-30
+27.6%
5-year compound annual growth
+20.3%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $83.05M | -37.6% | 2026-03-23, Balance as of period end |
| 2024-12-31 | $133.03M | n/m | 2026-03-23, Balance as of period end |
| 2023-12-31 | $7.30M | n/m | 2025-03-20, Balance as of period end |
| 2022-12-31 | -$10.91M | n/m | 2024-03-29, Balance as of period end |
| 2021-12-31 | $23.08M | -6.0% | 2023-03-29, Balance as of period end |
| 2020-12-31 | $24.56M | +17.0% | 2022-03-02, Balance as of period end |
| 2019-12-31 | $21.00M | +0.4% | 2021-03-08, Balance as of period end |
| 2018-12-31 | $20.91M | -25.0% | 2020-03-11, Balance as of period end |
| 2017-12-31 | $27.86M | n/m | 2019-03-18, Balance as of period end |
| 2016-12-31 | $207.0K | -98.4% | 2018-04-02, Balance as of period end |
| 2015-12-31 | $13.08M | n/m | 2018-04-02, Balance as of period end |
| 2014-12-31 | -$26.33M | n/m | 2017-03-14, Balance as of period end |
| 2013-12-31 | -$17.85M | n/a | 2016-03-23, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $83.05M | -37.6% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $41.98M | -54.5% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $2.76M | n/m |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $24.10M | -64.8% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $6.31M | +25.3% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $224.89M | +82.1% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $13.39M | +19.4% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | -$17.51M | n/m |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $7.83M | -76.1% |
Compare AVTX, CNTB, HCWB, INO side by side · Screen every company in Pharmaceutical Preparations ↗